DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,630,407 | -20.7% | 3,306,965 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $37,374,605 | +23.9% | 3,322,187 | +26.8% | 0.00% | 0.0% |
| Q1 2023 | $30,173,428 | -0.6% | 2,619,221 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $30,349,783 | -5.4% | 2,618,618 | +3.7% | 0.00% | 0.0% |
| Q3 2022 | $32,069,000 | +88.6% | 2,525,067 | +2.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000,000 | -25.4% | 2,474,498 | +4.6% | 0.00% | 0.0% |
| Q1 2022 | $22,797,000 | -20.5% | 2,364,981 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $28,671,000 | -11.2% | 2,411,397 | +21.3% | 0.00% | 0.0% |
| Q3 2021 | $32,288,000 | -22.2% | 1,988,152 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $41,494,000 | +115.2% | 1,972,208 | +58.8% | 0.00% | 0.0% |
| Q1 2021 | $19,284,000 | -11.4% | 1,241,711 | +19.8% | 0.00% | 0.0% |
| Q4 2020 | $21,757,000 | +254.5% | 1,036,117 | +240.8% | 0.00% | – |
| Q3 2020 | $6,137,000 | – | 304,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |